Ran-Perindopril 4 mg Tablets
PDF Leaflet Revision Date: 25 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension and congestive heart failure.
Dosage (summary)
Initial 4 mg daily, may increase to 8 mg based on response.
Onset of Action / Duration
Onset: 4-6 hours, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; safety in lactation not established.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- Aliskiren
- Fluoroquinolones
Contraindications
- Hypersensitivity to perindopril
- History of angioedema
- Severe renal impairment
- Bilateral renal artery stenosis
Common side effects
- Dizziness
- Cough
- Hypotension
- Hyperkalaemia
Counselling Points
- Take in the morning before breakfast
- Monitor blood pressure regularly
- Report any signs of angioedema immediately
Serious warnings
- Risk of angioedema
- Symptomatic hypotension
- Renal impairment
Important Disclaimer
The Ran-Perindopril 4 mg Tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
